The Application of Multimodal Ultrasound Imaging in Carpal Tunnel Syndrome
1 other identifier
observational
40
0 countries
N/A
Brief Summary
The aim of this study is to explore the application value of multimodal ultrasound parameters in the diagnosis and treatment follow-up of Carpal Tunnel Syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2025
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2024
CompletedFirst Posted
Study publicly available on registry
January 9, 2025
CompletedStudy Start
First participant enrolled
February 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
ExpectedJanuary 9, 2025
January 1, 2025
10 months
December 22, 2024
January 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Boston Carpal Tunnel Syndrome Questionnaire ,BCTQ
The Boston Carpal Tunnel Score is a patient-reported questionnaire that examines symptom severity and overall functional status of patients with carpal tunnel syndrome. The Symptom Severity Scale (SSS) with 11 questions is scored on a Likert scale of 1-5 and the Functional Status Scale (FSS) with 8 questions is scored from 1-5 with 1 as no difficulty and 5 as difficult.The higher scores mean a worse outcome.
1,3,6,12 months
Secondary Outcomes (2)
the patient's sensory nerve conduction velocity (SNCV)
3,6,12months
the patient's distal motor latency (DML).
3,6,12months
Interventions
Under ultrasound guidance, a mixed solution of corticosteroids and local anesthetics is injected around the nerve, followed by release of the transverse carpal ligament.
Eligibility Criteria
This study primarily utilizes ultrasound multimodal imaging to observe the changes in multiple parameter indicators before and after the treatment of nerve hydrodissection combined with transverse carpal ligament release in patients clinically diagnosed with mild to moderate Carpal Tunnel Syndrome.
You may qualify if:
- Age between 18 and 70 years;
- Presence of sensory abnormalities and motor dysfunction in the median nerve distribution area;
- Positive Tinel's sign or Phalen's test;
- Neurophysiological examination consistent with mild to moderate Carpal Tunnel Syndrome.-
You may not qualify if:
- Severe Carpal Tunnel Syndrome;
- Concurrent rheumatic, metabolic, systemic, or other systemic diseases;
- Concurrent cervical spondylosis or other peripheral neuropathies;
- Wrist joint trauma, surgery, space-occupying lesions, or nerve itself with space-occupying lesions;
- Concurrent malignant tumors or severe cardiopulmonary diseases;
- History of previous wrist surgery or injections;
- Pregnancy;
- Allergy to corticosteroids or local anesthetics.-
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Study Record Dates
First Submitted
December 22, 2024
First Posted
January 9, 2025
Study Start
February 1, 2025
Primary Completion
December 1, 2025
Study Completion (Estimated)
December 1, 2028
Last Updated
January 9, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share